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Abstract
Pyridoxal 59-phosphate (PLP), the active form of vitamin B6, has been implicated in preventing human pathologies, such as
diabetes and cancer. However, the mechanisms underlying the beneficial effects of PLP are still unclear. Using Drosophila as
a model system, we show that PLP deficiency, caused either by mutations in the pyridoxal kinase-coding gene (dPdxk) or by
vitamin B6 antagonists, results in chromosome aberrations (CABs). The CAB frequency in PLP-depleted cells was strongly
enhanced by sucrose, glucose or fructose treatments, and dPdxk mutant cells consistently displayed higher glucose
contents than their wild type counterparts, an effect that is at least in part a consequence of an acquired insulin resistance.
Together, our results indicate that a high intracellular level of glucose has a dramatic clastogenic effect if combined with PLP
deficiency. This is likely due to an elevated level of Advanced Glycation End-products (AGE) formation. Treatment of dPdxk
mutant cells with a-lipoic acid (ALA) lowered both AGE formation and CAB frequency, suggesting a possible AGE-CAB
cause-effect relationship. The clastogenic effect of glucose in PLP-depleted cells is evolutionarily conserved. RNAi-mediated
silencing of PDXK in human cells or treatments with PLP inhibitors resulted in chromosome breakage, which was
potentiated by glucose and reduced by ALA. These results suggest that patients with concomitant hyperglycemia and
vitamin B6 deficiency may suffer chromosome damage. This might impact cancer risk, as CABs are a well-known
tumorigenic factor.
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Introduction
It is now widely accepted that chromosome aberrations (CABs)
can contribute to cancer development. Deletions, duplications and
chromosome exchanges such as dicentrics and translocations can
ultimately result in loss of genetic material (loss of heterozygosity),
DNA amplification and formation of aberrant gene fusions, thus
promoting carcinogenesis [1–3]. Tumor development has been
also associated with chromothripsis, a phenomenon of massive
DNA fragmentation followed by multiple chromosomal rear-
rangements involving between one and a dozen of chromosomes
[4–6]. It is currently unclear whether cells with chromothripsis are
generated by a single event or result from multiple successive
events involving more than one cell cycle [7–9].
Abundant evidence indicates that CABs are mainly generated
by unrepaired or improperly repaired double strand breaks
(DSBs). DBSs can be induced by external agents such as ionizing
radiations and chemical mutagens or by endogenous factors such
as the free radicals generated by the oxidative metabolism or
errors in DNA replication [10–13]. DSBs are repaired through
two distinct but interconnected mechanisms - non-homologous
end joining (NHEJ) and homologous recombination (HR)- both
of which are mediated by evolutionarily conserved proteins.
NHEJ joins broken chromosome ends directly and relies on the
activities of the Mre11-Rad50-Nbs (MRN) complex, the Ku
heterodimer, and the Ligase 4 complex. HR and its variant single
strand annealing (SSA) are based on recombination with
homologous genomic sequences, and exploit a variety of factors
including the MRN complex, RAD51, BRCA1, BRCA2, BLM
and ATM [10]. Mutations in ATM (Ataxia Telangiectasia
Mutated), MRE11, NBS1 (Nijmegen Breakage Syndrome),
BRCA1 (Breast Cancer 1), BRCA2 and Ligase 4 cause human
syndromes characterized by both CABs and cancer predisposi-
tion, highlighting the connection between CABs and cancer
[14,15].
Several studies have shown that inadequate intake of micro-
nutrients results in DNA damage and cancer in humans [16,17].
A micronutrient that protects from DNA damage and is
beneficial for cancer prevention is Pyridoxal 59-phosphate (PLP)
[16,18–20]. PLP is the metabolically active form of vitamin B6
generated by pyridoxal kinase; it acts as a cofactor for more than
140 enzymes, which catalyze a myriad of biochemical reactions.
It has been estimated that PLP is involved in 4% of all catalytic
activities and it is known to play essential roles in wide range of
metabolic and developmental processes including amino acid,
fatty acid and neurotransmitter metabolism [19–21]. There is
also evidence that PLP quenches the oxygen reactive species
acting as a potent antioxidant [22–24] and antagonizes Advanced
Glycation End-products (AGE) formation [19,25,26].
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Based on its wide range of functions it is not surprising that PLP
is beneficial for many human diseases. Indeed, many epidemio-
logical studies indicate that PLP protects from cancer, diabetes,
cardiovascular diseases and neurological disorders [19,20]. How-
ever, the mechanisms underlying the effects of PLP at the
molecular and cellular levels are still poorly understood. Here we
show that in both Drosophila and human cells an elevated
intracellular level of glucose has a dramatic clastogenic effect if
combined with PLP deficiency; some cells exhibit an extensive
chromosome damage that is reminiscent of chromothripsis. In
addition, we show that PLP deficiency greatly potentiates AGE
formation. Our findings suggest vitamin B6 deficiency coupled
with hyperglycemia results in chromosome damage, which might
promote carcinogenesis.
Results
Mutations in the dPdxk gene cause chromosome
aberrations
We identified a mutation (dPdxk1) in the Drosophila gene
encoding pyridoxal kinase (Pdxk) by a cytological screen of 1680
third chromosome lines bearing recessive mutations that cause
death at late larval stages (see Materials and Methods). Pdxk plays
a critical role in the formation of pyridoxal 59-phosphate (PLP), the
active form of vitamin B6 [19]. Mitotic cells from colchicine-
treated dPdxk1 mutant brain displayed ,6% chromosome
aberrations (CABs); the frequency of aberrations in wild type cells
is,0.5% (Fig. 1A–C). Genetic analyses placed dPdxk1 in the 67A9-
67B2 polytene chromosome interval that contains only 11 genes
(figure S1A). A mutation in one of these genes, l(3)67Ab, failed to
complement dPdxk1 and has been thus renamed dPdxk2. The
frequencies of CABs observed in dPdxk1/Df(3L)AC1 (67A2-67D11)
and dPdxk2/Df(3L)AC1 hemizygotes were significantly higher than
those seen in the respective dPdxk1 and dPdxk2 homozygotes
(Figures 1C and S1A), suggesting that both mutant alleles are
hypomorphic.
DNA sequencing showed that both dPdxk1 and dPdxk2 carry
lesions in the Pdxk-encoding CG34455 gene, which specifies a 304
aa protein (http://flybase.org). dPdxk1 carries an ARG transition
(# 338) in a splicing acceptor site, which is predicted to lead to a
truncated protein of 83 aa; dPdxk2 carries a TRC transition (#
700) that leads to a phenylalanine to serine substitution in the
active site of Pdxk. To confirm the identity of the dPdxk gene we
performed complementation tests with three different transgenes:
one contained the endogenous promoter and the CG34455
genomic sequence fused in frame with the GFP sequence; the
other transgenes were both placed next to the tubulin promoter
and contained either the CG34455 or the human PDXK cDNA
fused in frame with the 3HA sequence (Figure S1B). All transgenes
rescued the CAB phenotype of dPdxk mutants; the transgene
placed under the control of the endogenous promoter also rescued
the dPdxk1 lethal phenotype.
Sugars increase the CAB frequency in dPdxk mutants
To ask whether the CAB phenotype was due to PLP deficiency,
we grew dPdxk mutant flies in food supplemented with 1022 M
PLP in 4% sucrose, or in a food supplemented with 4% sucrose
only (protocol 1, Figure 1B). The PLP-containing food completely
suppressed the CAB phenotype. However, to our surprise, dPdxk
mutant larvae grown in the food with only sucrose displayed a 3-
fold increase in CAB frequency compared to mutant larvae grown
in normal food (Figure 1D). Because larval feeding does not allow
precise control of sugar and PLP intake, we incubated dissected
brains from third instar larvae for 4 h in saline/FBS (0.7% NaCl
supplemented with 10% fetal bovine serum) containing defined
quantities of sugars or drugs (protocol 2, Figure 1B). This analysis
revealed that 1% glucose causes substantial increases in the CAB
frequency in both dPdxk1 (3.5-fold) and dPdxk2 (4.1-fold) mutant
brains (Figure 1E). The effects of 1% fructose were even more
dramatic, as it caused 6.9 and 10.3-fold increases in the CAB
frequency in dPdxk1 and dPdxk2 brains, respectively. 1% glucose or
fructose did not induce CABs in wild type brains (see Figure 2B
below and data not shown). Most importantly, the clastogenic
effects of sugars were drastically reduced by 1 mM PLP
(Figure 1E).
In addition to glucose and glycogen Drosophila cells and
hemolymph contain trehalose, a disaccharide formed from two
glucose moieties. Trehalose is a particularly stable high-energy
storage molecule that can be transported and accumulated to
high concentrations without toxic effects [27]. We thus focused
on glucose and measured its concentration in dPdxk mutant
tissues. Using a Hexokinase-based detection method, we found
that the hemolymph of dPdxk1 larvae contains nearly twice as
much glucose as that of wild type larvae (Figure 2A). We next
analyzed the dose-effect relationships between the intracellular
glucose concentration (IGC) in larval brain cells and the CAB
frequency. Dissected brains were incubated for 4 h in saline/FBS
with increasing glucose concentrations and then examined for
both the IGC and the presence of CABs (protocol 2, Figure 1B).
In dPdxk1 brains exposed at high glucose concentrations the
frequency of cells with more than 5 CABs was quite high
(Figure 2B) and in many cases the CAB number per cell could not
be assessed. Thus, in order to render the data comparable, we
considered the frequency of cells with CABs instead of the CAB
frequency (number of CABs/number of cells scored) as in
Figure 1C–E. In dPdxk1 mutant brains, the frequency of cells with
CABs increased with the IGC (Figure 2B). In wild type brains
treated with 1% or 5% glucose, the frequencies of cells with
broken chromosomes were comparable to that of non-treated
controls, and only treatments with 10% glucose resulted in a
significant CAB increase (Figure 2B). Importantly, wild type and
dPdxk1 brains with comparable IGCs (wt brains in 10% glucose
and dPdxk1 brains in 5% glucose) displayed significantly different
frequencies of cells with CABs, with mutant brains showing a
higher frequency of metaphases with damaged chromosomes
than controls (Figure 2B). These results indicate that CABs are
Author Summary
We show that the active form of vitamin B6 (Pyridoxal 59-
phosphate, PLP) plays an important role in the mainte-
nance of genome integrity. We found, using Drosophila as
a model system, that PLP deficiency results in chromosome
breaks and rearrangements (collectively dubbed chromo-
some aberrations, abbreviated with CABs). Most impor-
tantly, we observed that in PLP deficient cells, sucrose,
glucose, or fructose strongly enhance the frequency of
CABs. The mutagenic effects of sugars in the presence of
PLP deficiency are evolutionarily conserved, as PLP
depletion or inhibition in human cells results in CAB
formation, which is potentiated by glucose or fructose.
These results suggest that patients with concomitant
hyperglycemic crises and vitamin B6 deficiency may suffer
genetic damage, which might promote cancer and
diabetes complications. Our work further suggests that
patients treated with PLP antagonist drugs should keep
under control the level of sugar in their blood and
compensate their vitamin B6 level.
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not caused by a high IGC only, but by the simultaneous
occurrence of an elevated IGC and a low PLP level. Thus, in the
presence of low PLP levels (as shown in later figure), sucrose,
glucose and fructose behave as potent clastogens.
Interestingly, in brains with high IGC approximately 10% of
the metaphases with more than 5 CABs showed an extensive
chromosome fragmentation (Figure 1A). The frequency of
chromosome breaks and rearrangements in the latter cells is
clearly much higher than that expected from a Poisson distribution
of CABs. The occurrence of this massive chromosome damage
might reflect an increase of IGC beyond a critical threshold in cells
where PLP is strongly reduced.
Figure 1. Clastogenic effects of sugar in PLP-deficient Drosophila brain cells. (A) Examples of CABs; the thin arrow and the arrowhead point
to a chromatid and an isochromatid deletion, respectively; the thick arrows point to multicentric chromosomes. The dPdxk mutant cell treated with
5% glucose (G) exhibits extensive chromosome fragmentation. Scale bar, 5 mm. (B) Scheme of the 2 experimental protocols used. Colch, colchicine
addition; Fix, fixation. (C) CAB frequencies in wild type (wt) and dPdxk mutants (protocol 1); Df is Df(3L)AC1 that uncovers dPdxk; (D) CAB frequencies
in wt and dPdxkmutant brains from larvae grown in normal medium and treated with either sucrose (S) or S plus PLP (protocol 1). (E) CAB frequencies
in wt and dPdxk mutant brains incubated in saline containing either 1% G or 1% fructose (F) with or without PLP (1 mM) (protocol 2). Each bar of the
C, D and E graphs represents the mean frequency of CABs (6SE) obtained by examining at least 800 metaphases from at least 8 brains. *, significantly
different in the Student t test with p,0.001.
doi:10.1371/journal.pgen.1004199.g001
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The spindles of glucose-treated dPdxk mutant brains are
resistant to colchicine
Additional evidence for a high IGC in dPdxk1 mutant brains was
provided by the analysis of mitosis in larval brains. We noticed that
preparations of dPdxk1 mutant brains incubated in 1% glucose
(protocol 2, Figure 1B), and treated for 90 min with 1025 M
colchicine before fixation, contain several anaphases. Immuno-
staining for tubulin revealed that these preparations display many
mitotic spindles with a slightly reduced microtubule (MT) density
but otherwise normal (Figure 3A–C). In contrast, preparations of
colchicine-treated wild type or dPdxk1 mutant brains did not
exhibit any recognizable spindle structure (Figure 3A). We thus
asked whether PLP addition alleviates the colchicine resistance of
the dPdxk1 mutant spindles incubated in 1% glucose. We found
that treatments with 1% glucose (protocol 2, Figure 1B) result in
40.3 % colchicine-resistant spindles. However, if brains were
incubated in both 1% glucose and 1 mM PLP, the frequency of
resistant spindles was only 20.1% (Figure 3D). These observations
suggest that addition of exogenous PLP compensates the PLP
deficiency caused by the dPdxk1 mutation, reducing the glucose
level and its effects on spindle MTs.
Tubulin tyrosination and detyrosination is a well-known
reversible enzyme-mediated post-translational modification that
affects MT stability. MTs that end with a tyrosine residue at the C-
terminus of a-tubulin (Tyr-MTs) are more dynamic and more
resistant to nocodazole-induced depolymerization than detyrosi-
nated MTs (usually called Glu-MTs because their C-terminal
residue is Glu instead of Tyr) [28,29]. Early studies showed that
human umbilical vein endothelial cells display colchicine-resistant
MTs and reduced proliferation when cultured in high glucose.
The MTs of these cells were characterized by frequent loss of the
terminal tyrosine residue and their colchicine resistance was
corrected by tyrosine addition [30,31]. Based on these results, we
incubated for 4 hours dPdxk1 mutant brains in saline/FBS
containing 1.7 mM tyrosine and 1025 M colchicine (added
90 min before fixation). These brains showed a substantial
reduction in the frequency of mitotic figures with undepolymerized
spindles compared to brains treated in the same way but without
tyrosine addition (18.3 vs 40.3 %); addition of glycine (1.7 mM)
instead of tyrosine did not affect the frequency of colchicine-
resistant spindles (Figure 3D). Thus, in line with the studies on
human umbilical vein endothelial cells, addition of tyrosine
corrects colchicine resistance also in Drosophila dPdxk mutant cells
that accumulate an elevated glucose amount.
We also studied the effect of tyrosine on CAB formation. We
examined the CAB frequencies in dPdxk mutant brains incubated
in either 1% glucose and 1.7 mM tyrosine or in 1% glucose only
(protocol 2, Figure 1B). We found that the frequency of CABs in
tyrosine treated brains (18.0 %; 8 brains; 506 metaphases) is not
significantly different from that of brains exposed to glucose only
(20.9 %; 8 brains; 367 metaphases). These results suggest that
colchicine-resistant spindles and CABs are unrelated outcomes of
PLP deficiency, as tyrosine affects spindle resistance but not CAB
formation.
PLP inhibitors mimic the effects of dPdxk mutations
There are several well-known PLP inhibitors, some of which are
used in pharmaceutical treatments. These drugs include the
vitamin B6 analog 4-deoxypyridoxine (4-DP), isoniazid (tubercu-
losis treatment, antidepressant), penicillamine (antirheumatic), and
cycloserine (tuberculosis treatment, antidepressant) [32,33]. Brains
from wild type larvae incubated for 4 hours in the presence of 4-
DP, isoniazid or penicillamine (protocol 2, Figure 1B) showed
higher levels of CABs than untreated controls (Figure 4). When
these brains were also exposed to 1% glucose, the CAB frequency
was further and significantly increased (Figure 4). Similarly, brains
from larvae grown in the presence of cycloserine displayed a
significant increase in CABs compared to untreated controls, and
this effect was potentiated by glucose addition (Figure 4). These
results indicate that glucose induces CABs when vitamin B6
activity is reduced by drug treatments.
dPdxk mutants are partially defective in insulin signaling
Studies on mammalian systems have shown that glucose
accumulation within the cell might depend on either lack of
insulin (type-1 diabetes) or defects in the insulin-signaling pathway
Figure 2. Relationships between PLP, glucose and CABs. (A) Glucose concentration in the hemolymph of wild type (wt) and dPdxk mutant
larvae. Columns are the means of 8 independent samples of 10 larvae6SE; *, glucose content is significantly higher than in wild type with p,0.001 in
the Student t test. (B) CAB frequencies and relative intracellular glucose (G) concentration in wild type (wt) and dPdxk mutant brains incubated in
saline/FBS with the indicated G contents (protocol 2; figure 1). 1, includes cells with .5 CABs. * and {, significantly different in the Student t test with
p,0.001 and p,0.05, respectively.
doi:10.1371/journal.pgen.1004199.g002
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(type-2 diabetes). Insulin promotes phosphorylation of AKT,
which leads to phosphorylation and inactivation of glycogen
synthase kinase 3 (GSK3) allowing glycogen formation (Figure 5A,
top). In the absence of insulin, the active form of GSK3
phosphorylates and inhibits glycogen synthase (GS), the enzyme
that catalyzes glycogen synthesis (Figure 5A, bottom) [34]. Thus
loss of AKT or lack of AKT phosphorylation should result in
glycogen synthesis inhibition and glucose accumulation.
Flies and mammalian systems employ similar mechanisms
(Figure 5A) for regulation of carbohydrate homeostasis (reviewed
Figure 3. The spindles of glucose-treated dPdxkmutant brains are resistant to colchicine-induced depolymerization. (A–C) Cells were
immunostained for tubulin (green) and DNA (blue). (A) Examples of metaphase figures from colchicine-treated wild type brains with completely
depolymerized spindles. (B) Examples of mitotic spindles of wild type brain neuroblasts. (C) Examples of colchicine-resistant spindles observed in
dPdxk mutant brains exposed to 1% glucose (G). These spindles exhibit a slightly reduced microtubule (MT) density but are otherwise normal. Scale
Bar, 5 mm. (D) PLP (1 mM), Tyrosine (1.7 mM) but not glycine (1.7 mM) partially restores colchicine sensitivity of glucose-treated dPdxk spindles. All
cells have been treated with 1025 M colchicine for 90 minutes. ‘‘Number of mitotic cells’’ is the total number of mitotic figures that exhibit DAPI-
stained chromosomes; ‘‘mitotic spindles (%)’’ is the frequency of mitotic cells that exhibit a colchicine-resistant spindle. Significantly different (*) with
p,0.01 or not different ({) from dPdxk mutant brains incubated in 1% G only (Student t test).
doi:10.1371/journal.pgen.1004199.g003
Sugar-Induced Chromosome Aberrations
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in [35,36]). The Drosophila genome encodes eight insulin-like
peptides (DILPs) that are considered orthologous to mammalian
insulin. These peptides are expressed in tissue- and stage-specific
manner during development [37–39]. DILP2 is the closest
homologue of human insulin and the most highly expressed DILP
in the two bilaterally symmetric clusters of brain cells dubbed
median neurosecretory cells (mNSCs) or insulin producing cells
(IPCs); mNSCs/IPCs produce Drosophila insulin and are the main
insulin suppliers during larval growth [37–39]. Using an antibody
that specifically recognizes the mNSCs/IPCs [40] we found that
dPdxk1 mutant brains show a normal concentration of DILP-2
(Figure 5B). We next tested whether exogenous insulin has the
ability of stimulating phosphorylation of Akt at Ser 505 in dPdxk1
mutant brains; this residue is homologous to mammalian Ser 473
whose phosphorylation promotes full Akt activation [41] (Figure 5).
After stimulation with human synthetic insulin, dPdxk1 mutant
brains displayed a limited but statistically significant reduction in
the Akt phosphorylation level compared to controls (Figures 5C, D
and S2). This suggests that glucose accumulation in dPdxk1
mutants is at least in part due to a defect in insulin signaling.
dPdxk mutants exhibit an increased uracil concentration
in larvae but are only slightly sensitive to hydroxyurea
PLP is cofactor of several enzymes involved in thymidylate
(dTMP) biosynthesis. It has been previously shown that mutants in
BUD16, the yeast gene that encode pyridoxal kinase, are defective
in dTMP synthesis and incorporate more uracil nucleotides in
their DNA than nonmutant controls [18]. Thus, in the attempt of
Figure 4. PLP inhibitors cause CABs and their clastogenic effect
is potentiated by glucose. CAB frequencies in wild type brains
treated with 4-DP (10 mM), isoniazid (Iso, 10 mM) penicillamine (Pen,
10 mM) in the presence or absence of 1% glucose (G) (protocol 2,
figure1B). In the cycloserine (Cyclo) experiment, larvae were grown for 6
days in food containing 10 mM cycloserine; dissected brains were then
incubated for 4 hours in saline/FBS with or without 1% G. Each bar in
the graphs represents the mean frequency of CABs (6SE) obtained by
examining at least 800 metaphases from at least 8 brains. * and **,
indicate significant difference with p,0.05 and p,0.001 in the Student
t test. Untreated wild type brains exhibit 0.5% CABs (see Figure 1).
doi:10.1371/journal.pgen.1004199.g004
Figure 5. dPdxk mutants are defective in the insulin signaling pathway. (A) Simplified representation of the insulin-signaling pathway; see
text for description. (B) Western blotting showing that dPdxk1 mutants contain normal levels of DILP2. (C) Akt phosphorylation levels in wild type (wt)
and dPdxk1 mutant brains with or without insulin stimulation; P-Akt is the phosphorylated (Ser 505) Akt protein recognized by phospho-specific
antibody; Pan-Akt is the is total Akt protein recognized by a specific antibody; Gio is a Drososphila Phosphatidylinositol transfer protein used as
loading control (see Methods). (D) Quantification of the Akt phosphorylation levels. The intensity of the P-Akt bands was normalized to both total Akt
and the Gio loading control. The columns are the means 6SE of 12 independent samples of 20 brains from 3 independent experiments (see
Methods); the wild type pAkt/panAkt/Gio ratio has been arbitrarily set equal to 1. *, significantly different with p,0.05 in the Student t test. A short-
exposure version of the blot from insulin-stimulated brains (Figure S2) provides visual evidence for a reduced P-Akt level in dPdxk mutants.
doi:10.1371/journal.pgen.1004199.g005
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defining the primary defect leading to CABs, we asked whether
dPdxk1 mutants accumulate uracil. We used HPLC/MS to
determine uracil concentration in larval extracts and found that
dPdxk1 mutant larvae exhibit lower dTTP and higher dUTP levels
compared with wild type controls (Figure 6A). HPLC/MS also
showed that the PLP level in dPdxk1 mutant larvae is approxi-
mately 50 % of that found in wild type controls (Figure 6A).
Because nucleotide unbalance can affect DNA synthesis and
cause CABs [42] we asked whether brain cells of dPdxk1 mutants
were sensitive to hydroxyurea (HU). HU is expected to cause a
DNA replication stress because inhibits ribonucleotide reductase
and thus decreases the production of deoxyribonucleotides. We
treated brains for 15 min with 2 mM HU and then placed them in
saline for 2.5 hours before fixation. This treatment did not
substantially reduce the mitotic index in control and mutant
brains. HU-treated dPdxk1 brains displayed a CAB frequency that
was only slightly higher than the sum of the frequencies observed
in HU-treated controls and in untreated dPdxk1 mutants
(Figure 6B). Thus, dPdxk mutations cause little or no increase in
the sensitivity of Drosophila cells to HU.
dPdxk mutations increase AGE formation
It has been reported that PLP counteracts AGE (Advanced
Glycation End products) formation [25,26]. AGEs are heteroge-
neous molecules formed after nonenzymatic glycosylation (glyca-
tion) of proteins, lipids, or nucleic acids. AGE formation has been
associated with the production of DNA damaging reactive oxygen
species, and with the progression of several disorders including
diabetes complications, neurodegenerative and cardiovascular
diseases [43,44]. Immunostaining with an anti-human AGE
antibody revealed that both untreated and glucose-treated dPdxk1
mutant brains (protocol 2; Figure 1B) consistently exhibit higher
frequencies of AGE-positive cells than wild type controls. Here
again, PLP addition prevented AGE formation (Figure 7A, B). We
next treated dPdxk1 brains with a-lipoic acid (ALA), an antioxidant
compound that antagonizes AGE formation and cooperates with
vitamin B6 in ameliorating insulin resistance in pre-diabetic rats
[45,46]. We incubated dPdxk1 brains in 10 mM ALA, with or
without glucose addition (protocol 2 Figure 1B). In all cases, ALA
reduced the frequencies of AGE positive cells. Interestingly, ALA
also reduced the frequency of CABs in both untreated and
glucose-treated dPdxk1 mutants (Figures 7B, C).
Glucose causes CABs in PLP deficient human cells
We finally asked whether glucose causes CABs in human cells
with reduced PLP levels. RNAi-mediated PDXK depletion in
HeLa cells (38 % of the control level; Figure 8A) resulted in a
dramatic increase of CABs (Figures 8B–E). In addition, PDXK
RNAi cells grown in media containing final glucose concentrations
of 0.9 % or 2.45 % showed significant CAB increases compared to
cells grown in standard medium (0.45 % glucose). Addition of PLP
(at a final concentration of 2 mM) to either the standard or the
2.45 % glucose medium strongly reduced the CAB frequency
(Figure 8E). Interestingly, PDXK RNAi cells exposed to high
glucose concentrations displayed several metaphases with exten-
sive chromosome fragmentation. These shattered metaphases
(Figure 8D) were similar to the metaphases with multiple breaks
observed in glucose-treated Drosophila Pdxk mutant brains
(Figure 1A). The frequency of such metaphases was higher in
fructose-treated cultures (2% fructose plus 0.45% glucose) than in
cultures exposed to 2.45% glucose (Figure 8E). Thus, fructose
appears to be more efficient than glucose in the induction of
chromosome shattering in both Drosophila and human PLP-
deficient cells.
We also found that HeLa cells behave as Drosophila brain cells in
their responses to the vitamin B6 analog 4-DP and ALA. 4-DP
caused extensive chromosome breakage in HeLa cells, which was
potentiated by a high glucose concentration. Treatment of PDXK-
depleted or 4-DP treated cells with ALA reduced the CAB
frequency (Figure 8C).
Discussion
Our results demonstrate that in organisms as distant as flies and
humans sugars become potent clastogens when PLP is reduced.
Previous studies showed that mutations in BUD16, the yeast gene
Figure 6. dPdxk1 mutations cause nucleotide unbalance but are only weakly sensitive to hydroxyurea (HU). (A) dPdxk1 mutant larvae
have a very low dTTP content and accumulate uracil; they also exhibit a reduced PLP level. Values are the means of three independent experiments
(6SD). * and **, indicate significant differences from wild type controls with p,0.05 and p,0.01, respectively. (B) dPdxk1 mutants are weakly sensitive
to HU. In HU-treated (2 mM) dPdxk1 mutant brains, 1.6 % of metaphases exhibited shattered chromosomes; these metaphase were rarely observed
(0.3%) in control and dPdxk1 untreated mutant brains. Each bar in the graph represents the mean frequency of CABs (6SE) obtained by examining at
least 600 metaphases form at least 6 brains.
doi:10.1371/journal.pgen.1004199.g006
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encoding pyridoxal kinase, result in chromosome rearrangements,
and that 4-DP induces DNA repair foci in human cells [18]. There
is also evidence that vitamin B6 antagonizes AGE formation
[19,25,26]. However, the deleterious genetic effects of sugars in
vitamin B6 deficient cells have never been demonstrated.
CAB formation and clastogenic effects of sugars in dPdxk
mutant cells
Studies on BUD16 yeast mutants showed that PLP is required for
dTMP biosynthesis [18]. Cells bearing mutations in BUD16
displayed excessive uracil incorporation into DNA compared to
wild type, a condition that may lead to DSBs via uracil excision and
production of abasic DNA sites. However, a deficiency of uracil
glycosylase, the main enzyme that removes uracil from DNA, did
not suppress the mutagenic effects of BUD16, indicating that uracil
excision is not a major cause of DNA damage in cells with low PLP
levels. Moreover, BUD16mutant cells showed an extreme sensitivity
to hydroxyurea (HU), which inhibits ribonucleotide reductase that
catalyzes the de novo synthesis of dNTPs. Based on these results, it
has been suggested that PLP deficiency in yeast leads to DNA
lesions and gross chromosomal rearrangements by causing a strong
nucleotide imbalance that impairs DNA synthesis [18].
We have shown that Drosophila cells bearing mutations in dPdxk
also exhibit a dUTP excess compared to wild type controls.
However, dPdxk mutant cells do not appear to be particularly
sensitive to HU. Untreated dPdxk1 mutant cells and HU-treated
wild type cells showed 6% and 4% CABs, respectively; HU-treated
dPdxk1 mutant cell displayed 16% CABs, a frequency that is only
slightly higher than the frequency expected (10%) if HU and
dPdxk1 mutations acted independently. In contrast HU-treated
brains of mutants in tim2, which encodes a replisome-associated
factor, showed a ,10-fold increase in the CAB frequency
compared to the sum of the frequencies observed in untreated
tim2 mutant cells and HU-treated controls [47]. The finding that
HU does not greatly exacerbate DNA damage in Drosophila dPdxk
mutants suggests that the primary cause of CAB formation in these
mutants is not nucleotide unbalance.
We have found that in both untreated and glucose-exposed dPdxk
mutant brains there is a substantial increase in AGE formation. Most
importantly we found that ALA reduces both AGE formation and the
CAB frequency. Given that AGE formation is accompanied by the
production of DNA damaging reactive oxygen species [43,44] and that
ALA is a potent antioxidant compound [46], we suggest that the DNA
damage leading to CABs in dPdxk mutants, and especially in dPdxk
mutants exposed to sugars, is at least in part a consequence of AGE
formation. It is also possible that the lesions that cause CABs are
generated by the simultaneous presence of AGE-linked reactive oxygen
species and an unbalanced nucleotide pool. In this context, we propose
that the higher frequency of CABs observed in fructose-treated brains
compared to those exposed to glucose (Figure 1E) might reflect the
higher efficiency of fructose in the initiation of the Maillard reaction
that leads to AGE formation [48–50].
Figure 7. dPdxk1 mutant brains exhibit higher frequencies of AGE-positive cells than wild type (wt) brains. (A) Examples of cells stained
with a rabbit anti-human AGE antibody. Scale bar, 5 mm. (B) Frequencies of AGE-positive cells in wild type (wt) and dPdxk mutant brains exposed to
different glucose (G) concentrations with or without ALA or PLP; bars represent the mean frequencies of AGE-positive cells (6SE) obtained by
examining at least 300 cells/brain in 4 brains. At all glucose concentrations untreated dPdxk1 mutant brains have a significantly higher frequency of
AGE-positive cells than wild type controls and either ALA or PLP treated dPdxk1 brains; (C) ALA reduces the frequency of CABs induced by dPdxk1 or
dPdxk1 plus 1% G. Each bar in the graph represents the mean frequency of CABs (6SE) obtained by examining at least 600 metaphases form at least 6
brains. * and **, significantly different in the Student t test with p,0.03 and p,0.001, respectively.
doi:10.1371/journal.pgen.1004199.g007
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Mutations in dPdxk lead to high intracellular glucose
concentrations
Our results clearly show that the hemolymph and the brain cells
of dPdxk mutants contain a higher glucose concentration than their
wild type counterparts. We have also shown that Pdxk mutant
brains incubated in glucose-enriched saline accumulate more
glucose than wild type brains. Our results suggest that the increase
in glucose concentration observed in Pdxk mutant brains is at least
in part due to an acquired insulin resistance. It has been recently
shown that Drosophila larvae reared on a high-sugar diet exhibit
diminished insulin-induced Akt phosphorylation at Ser 505
compared to controls grown in normal medium [41]. However,
the reduction in Akt phosphorylation observed in larvae grown in
a sugar-rich medium [41] is substantially stronger than that found
in Pdxk mutants. A possible reason for this difference in the
response to insulin stimulation might be the time of exposure to
Figure 8. PLP deficiency causes CABs in HeLa cells. (A) Western blots showing that RNAi against PDXK in HeLa cells reduces the level of the
PDXK protein to the 38% of the control level. (B–D) Examples of control and PDXK RNAi HeLa cells exposed to different glucose concentrations; the
metaphase in panel D exhibits extensive chromosome breakage (ECB); the thin arrows point to chromosome fragments and the thick arrow to a
dicentric chromosome. Scale bar, 10 mm. (E) CAB frequencies in mock-treated and PDXK RNAi (abbreviated with RNAi) cells incubated in media
containing different glucose (G) or fructose (F) concentrations with or without PLP (2 mM); 1, includes cells with ECB; * and {, significantly different in
x2 test with p,0.05 and p,0.001 respectively. (F) 4-DP (30 mM) induces CABs in HeLa cells, and this effect is potentiated by G; in contrast, ALA
(10 mM) reduces the frequency of CABs induced by RNAi against PDXK. 1, includes cells with ECB; * and {, significantly different in x2 test with
p,0.001 and p,0.01, respectively.
doi:10.1371/journal.pgen.1004199.g008
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high sugar. Larvae grown in sugar-rich medium were exposed to
sugar throughout development. In contrast, it is likely that in dPdxk
mutant larvae the maternal supply of Pdxk was progressively
diluted during development becoming critically depleted only in
late larval stages [51]. However, while this interpretation explains
the differences between our data and those of Musselman and
coworkers [41], it does not explain how dPdxk mutant acquired
insulin resistance. We propose that PLP deficiency leads to an
initial glucose accumulation through an as yet unknown mecha-
nism and that this accumulation leads to insulin resistance.
According to this interpretation, dPdxk mutant brains incubated in
glucose- or fructose-enriched saline accumulate more sugar than
wild type brains through two mechanisms, one linked to PLP
deficiency per se and the other linked to insulin resistance.
The mitotic spindles of dPdxk mutant are resistant to
colchicine
The mitotic spindles of dPdxk mutant brains incubated in 1%
glucose displayed an unexpected resistance to colchicine-induced
depolymerization. This resistance was attenuated by treatment
with tyrosine but not with glycine. Early work on human umbilical
vein endothelial cells (HUVEC) has suggested a possible interpre-
tation of these results. Culture of HUVECs in high glucose
resulted in frequent loss of the terminal tyrosine residue from MTs,
colchicine-resistant MTs and reduced cell proliferation [30,31].
Colchicine resistance was attributed to tubulin detyrosination at
MT ends, a reversible modification that renders MTs less dynamic
and less resistant to nocodazole-induced depolymerization than
tyrosinated MTs [28,29]. Consistent with this interpretation La
Selva and coworkers [31] showed that the defect in cell
proliferation was corrected by tyrosine addition to the tissue
culture medium. These authors did not attribute the loss of
terminal tyrosine to tubulin glycation because they found that L
glucose, which is not metabolized but can form Amadori bonds
with protein amino groups, did not inhibit HUVEC proliferation.
There is abundant evidence that tubulin glycation can occur.
For example in vitro glycation of rat brain tubulin increases with
glucose concentration, and diabetic rats display a dramatic
increase in glycosylated tubulin and defective tubulin polymeriza-
tion [52]. Moreover recent work has shown that tyrosine
glycosilation can occur also in humans [53]. Thus, although to
the best of our knowledge there is no experimental evidence that
tyrosine glycosylation can regulate MT dynamics, one can
envisage that high intracellular glucose concentrations might
cause tyrosine glycation. Under this assumption, the high glucose
concentration in dPdxk1 mutant cells would cause tyrosine
glycation leading to detyrosinated MTs and colchicine resistance;
addition of an excess of tyrosine would dilute the glycosylated
tyrosine moiety, partially restoring the sensitivity of MTs to
colchicine. Whatever the mechanism underlying the colchicine
resistance of PLP depleted cells grown in high sugar, our finding
has a potential translational impact and merits further study. An
extrapolation of our results to human tumor therapy predicts that
patients with vitamin B deficiency and hyperglycemia might be
resistant to chemotherapy with MT-depolymerizing agents.
The chromosome damage induced by PLP deficiency in
HeLa cells is potentiated by sugar
Our experiments on HeLa cells have shown that the clastogenic
effects of glucose and fructose in vitamin B6-deficient cells are
evolutionarily conserved. HeLa cells in which the PDXK level was
reduced to 38% of the control level by RNAi, displayed a 22-fold
increase in the frequency of metaphases with CABs compared to
non-RNAi cells. Both RNAi and non-RNAi cells were grown in
standard DMEM medium, which contains 0.45% glucose and
thus exceed the normal glucose concentration in blood, which is
around 0.1 %. PDXK RNAi cells grown in DMEM containing
final glucose concentrations of 0.9 % or 2.45 % (or 0.45 % glucose
and 2% fructose) showed significant CAB increases compared to
those grown in standard medium. Addition of PLP to either the
standard or the 2.45% glucose medium strongly reduced the CAB
frequency in PDXK RNAi cells. In addition, the PLP inhibitor 4-
DP behaved as strong clastogen in HeLa cells, and its effect was
potentiated by glucose addition to the medium. Together these
results indicate that even moderate reductions in PLP level, such as
that caused by a 62% diminution of PDXK, can results in a high
CAB frequency. However, is possible that the elevated CAB
frequency observed in PDXK RNAi cells is at least in part a
consequence of the concomitant PLP deficiency and high glucose
concentration (0.45%) in the standard DMEM medium used to
grow HeLa cells. The central issue raised by these results is
whether the clastogenic effects of sugars can occur in human
patient with a vitamin B6 deficiency. We believe that this is quite
possible, as deficiency of this vitamin can be caused by many
dietary, genetic and pharmacological factors [54] and blood
glucose level over 0.5% (500 mg/dL) have been observed in
patients with hyperglycemic crises [55]. It is also conceivable that
even relatively limited glycemia increases would cause CABs in
people with particularly severe PLP deficiencies.
An interesting observation made on both Drosophila and human
cells is that PLP deficiency accompanied by high sugar results in
several metaphases with extensive chromosome fragmentation.
The frequency of CABs in these metaphases is much higher than
that expected from the Poisson distribution of CABs, suggesting
that these CABs might result from the synergistic combination of
two at least in part independent events such as PLP reduction and
sugar increase. Given that PLP and sugar concentration can
fluctuate we speculate that during interphase a small fraction of
the cells that suffer PLP deficiency/high sugar can rapidly revert to
relatively normal metabolic condition through either a PLP
increase or a sugar decrease. This situation would results in
chromosome shattering followed by DNA repair in a relatively
normal cellular environment and might therefore give rise to cells
with multiple and stable rearrangements such as those observed in
chromothripsis [4–6,56].
PLP deficiency and human health
Inadequate intake of vitamin B6 has been associated with
cancer risk [16,57–59] and recent studies have shown that a high
expression level of PDXK has a positive impact on survival of non-
small cell lung cancer (NSCLC) patients [60]. In addition, growing
evidence indicates that diabetes patients have a higher risk of
various types of cancer [61–65]. Our findings provide an
important link between these studies, suggesting that vitamin B6
deficiency accompanied by hyperglycemia might lead to chromo-
some damage and thus trigger carcinogenesis [1–3]. Our work
further suggests that patients with hyperglycemia who also take
drugs that antagonize PLP, should compensate by taking extra
amounts of vitamin B6. Conversely, patients chronically treated
with drugs that antagonize PLP should keep under control the
level of sugar in their blood.
Methods
Drosophila strains
dPdxk1 was isolated by a cytological screen of larval brain
squashes from a collection of 1680 EMS-induced late lethals
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generated in Charles Zuker’s laboratory (University of California,
San Diego). dPdxk2 [or l(3)67Ab], Df(3L)29A6, Df(3L)AC1 and
Df(3L)ED4416 were all obtained from the Bloomington Stock
center. The dPdxk mutations and the deficiencies were balanced
over TM6B or TM6C, which carry the dominant larval marker
Tubby (http://flybase.bio. indiana.edu/); homozygous and hemi-
zygous mutant larvae were recognized for their non-Tubby
phenotype. Germline transformation and complementation anal-
ysis are illustrated in Figure S1. All stocks were maintained on
standard Drosophila medium at 25uC.
Treatments of larvae and isolated brains
Flies were grown in standard Drosophila medium containing 4.5
% sucrose, and experiments were performed at 25 Cu. To analyze
the effects of dPdxkmutations and drug treatments we followed two
different protocols (Figure 1B). In both protocols, wild type or
dPdxk mutant larvae were grown in fly medium for 6 days with or
without addition of sugars or drugs. In protocol 1, brains dissected
from 6-day third instar larvae were incubated for 90 min in 2 ml
of saline (0.7% NaCl) and 1025 M colchicine and then fixed. In
protocol 2, brains dissected from third instar larvae were
incubated in 2 ml of saline supplemented with 10% fetal bovine
serum (FBS, Gibco BRL) for 4 hours with or without addition of
sugar or drugs and then fixed; 90 min before fixation colchicine
(final concentration, 1025 M) was added to the saline/FBS to
collect metaphases. In the experiments with hydroxyurea (HU), we
used a protocol different from those described in Figure 1B. Brains
form six-day old third instar larvae were incubated for 15 min in
saline with 2 mM HU (Sigma), washed, placed in saline for 2.5 h
and then fixed; 1 h before fixation, brains were treated with
1025M colchicine.
Chromosome cytology and immunostaining
Drosophila metaphase chromosome preparations were obtained
as previously described [66] and mounted in Vectashield H-1200
with DAPI (Vector Laboratories) to stain the chromosomes. Brain
preparations for immunofluorescence and tubulin immunostaining
were carried out according to Bonaccorsi et al. [67]. To stain the
AGEs, brain squashes were incubated overnight at 4uC with a
rabbit anti-human AGE antibody (1:200 in PBS; ab23722,
Abcam, UK), which was detected by a 1-hour incubation at
room temperature with Alexa 555-conjugated goat anti-rabbit IgG
(H+L) (1:300 in PBS, Molecular Probes). Immunostained prepa-
rations were mounted in Vectashield medium H-1200 with DAPI.
Observations were carried out using a Zeiss Axioplan fluorescence
microscope equipped with CCD camera (Photometrics CoolSnap
HQ).
Glucose concentration and insulin pathway analysis
Glucose concentration in Drosophila hemolymph and brains was
measured using the Infinity Glucose Hexokinase reagent (Thermo
scientific). To measure glucose in the hemolymph, samples of 10
larvae were washed in NaCl 0.7%, 0.1% Triton X-100 and then in
d-H2O. The hemolymph of these larvae was collected and its
glucose content measured following the protocol of Rulifson et al.
[38]. The values reported in Figure 2A are the means 6SE of 8
samples of 10 larvae. To measure glucose in brains, samples of 20
brains were placed in 40 ml of 1023 M EDTA, 1022M KH2PO4,
and the complete protease inhibitor cocktail (Roche), mechanically
homogenized and then centrifuged at 14,000 rpm for 10 min. The
supernatant was collected with a micropipette and used for glucose
measurement according to Rulifson et al. [38]. The measures
reported in Figure 2B are the means 6SE of 4 samples of 20
brains.
Insulin stimulation of Akt phosphorylation was performed using
recombinant human insulin (Sigma, I0516). Before stimulation,
larvae were starved for 5 hours in an empty vial humidified with a
drop of saline devoid of FBS. We then followed the protocol
described by Musselman et al. [41]. However, at the end of the
insulin stimulation procedure, instead of larvae, we homogenized
samples of 20 isolated brains, which were then used for Western
blotting analysis.
Uracil and PLP quantitation
To quantitate nucleotides and PLP in larval extracts we used the
HPLC/MS method described by D’alessandro et al. [68]. Briefly,
third instar larvae (20 per sample) were washed in saline,
homogenized, and then resuspended in 80 ml methanol; 100 ml
of chloroform were then added to each tube. After 30 min mixing,
20 ml of ice-cold ultra-pure water was added to the tubes, which
were centrifuged at 1,000 g for 1 min and then transferred to
220uC. After thawing, liquid phases were recovered and mixed to
an equivalent volume of acetonitrile. The tubes were then
centrifuged at 10,000 g for 10 min; the supernatants were
recovered into 2 ml tubes, dried to obtain visible pellets, and
resuspended in 200 ml of 5% formic acid in water. For metabolite
separation we used an Ultimate 3000 high-resolution fast HPLC
system (LC Packings, DIONEX, Sunnyvale, USA), with a Dionex
Acclaim RSLC 120 C18 column ‘‘2.1 mm6150 mm, 2.2 mm’’. A
0–95 % linear gradient of solvent A (0.1% formic acid in water) to
B (0.1% formic acid in acetonitrile) was employed over 15 min
followed by a solvent B hold of 2 min, returning to 100% A in
2 min and a 6 min post-time solvent A hold. ESI mass
spectrometry was performed as described previously using a High
Capacity ion Trap HCTplus (Bruker-Daltonik, Bremen, Ger-
many) [68]. Validation of HPLC/MS-eluted metabolites was
performed by comparison with the standard metabolites. ANOVA
statistical analysis was carried out using GraphPad Prism 5
software.
Western blotting and P-Akt measurement
Extracts for Western blotting of Drosophila proteins were
prepared by lysing samples of 20 brains in 150 mM NaCl,
50 mM Tris-Hcl pH 7.5, 30 mM NaF, 25 mM b-glycerophos-
phate, 0.2 mM Na3VO4, Triton X-100 1%, and Complete
protease inhibitor cocktail (Roche). Extracts were immunoblotted
according to Somma et al. [69]; blotted proteins were detected
using rabbit anti-DILP2 (1:2000; a gift of E. Hafen), rabbit anti-
Phospho (Ser 505)-Drosophila Akt (1:1000; #4054, Cell Signaling),
or rabbit anti-pan-Akt (1:1000; #4691, Cell Signaling).
To determine the phosphorylation level of Akt we performed
three different experiment similar to that shown in Figure 5C. We
thus analyzed twelve 20-brain independent samples for wild type
or dPdxk mutant third instar larvae. In each experiment we
determined the intensities of P-Akt bands normalized to both total
Akt and the loading control [Giotto (Gio) a Drosophila Phospha-
tidylinositol transfer protein; ref [70]. Measurements were
performed on unsaturated bands using Image J software (http://
rsb.info.nih.gov/ij/) for band quantification and normalization.
Human cell procedures
HeLa cells were grown in DMEM (Gibco BRL) with 10% fetal
bovine serum (FBS, Gibco BRL) in a humidified 5% CO2
atmosphere. PDXK siRNAs (SIHK1569, Sigma) were transfected
using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions. Mock-transfected and siRNA-transfected cells
where grown for 24 hours in normal medium, which was then
supplemented with glucose, fructose, PLP (2 mM), ALA (10 mM)
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or 4-DP (30 mM). In all cases, 72 hours after the beginning of
treatments colcemid (0.05 mg/ml, Gibco BRL) was added to the
cultures for 3 hours before fixation according to Revenkova et al.
[71]. Chromosome preparations were mounted in Vectashield H-
1200 with DAPI. Human cell extracts were prepared according to
Cherubini et al. [72], and Western blotting was performed as
described in Somma et al. [69]; PDXK was detected using a
mouse anti-PDXK antibody (1:500; 89006590, Abnova)
Supporting Information
Figure S1 Mapping and functional characterization of the dPdxk
gene. (A) Deficiency mapping of the dPdxk1 mutations. The
deficiencies that uncover the mutation are depicted in blue. (B)
Constructs and vectors used for germline transformation and
complementation analysis. The DNA fragment cloned into the
pUAST vector [73] spans the promoter and the genomic region of
the dPdxk gene (nucleotides 9352513-9354820); the other two
constructs were cloned in a pCaSpeR-tubulin vector [74]. Germline
transformation was carried out using standard methods. Comple-
mentation analysis was carried out using flies bearing the transgene
on the second chromosome. Tr/CyO; dPdxk1/TM6B flies (Tr
designates any homozygous viable transgene) were mated inter se
to build Tr/Tr; dPdxk1/TM6B stocks. Tr/Tr; dPdxk1/dPdxk1 animals
from these stocks were then examined for viability and the presence
of CABs in larval brains. All transgenes rescued the CAB phenotype
of dPdxk mutants; the transgene placed under the control of the
endogenous promoter also rescued the dPdxk1 lethal phenotype.
(TIF)
Figure S2 Levels of phosphorylated Akt (P-Akt) in insulin-
stimulated wild type (wt) and dPdxk mutant brains. The Western
blot (WB) shown here is a short-exposure version of the WB of
Figure 5, but it does not include Pan-Akt immunostaining, which
was obtained after stripping the membrane stained for P-Akt and
Giotto (Gio). Note that the P-Akt bands are more intensely stained
in wild type than in dPdxk mutants.
(TIF)
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